CNBCEN
Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
🇺🇸 United States / English
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Sky NewsEN
Mounjaro rollout on NHS needs 'urgent' boost, say MPs
Plans for rolling out weight-loss drug Mounjaro are "unambitious" and will reach a "woefully small number of people", according to MPs.
VRT NWSNL
Minister Vandenbroucke houdt terugbetaling obesitasmedicijn Mounjaro tegen
Minister van Volksgezondheid Frank Vandenbroucke (Vooruit) heeft beslist om het populaire obesitasmiddel Mounjaro niet terug te betalen. Dat schrijven De Tijd en L'Echo, en de minister bevestigt het nieuws aan VRT NWS. Eerder had Vandenbroucke al dezelfde keuze gemaakt voor het obesitasmiddel Wegovy.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.